Patents Assigned to MANYSMART THERAPEUTICS, INC.
  • BISPECIFIC T CELL ENGAGER AND USES THEREOF
    Publication number: 20210261645
    Abstract: A novel fusion protein to overcome the current difficulties related to application of monoclonal antibodies in disease treatment and in other fields, particularly those requiring ADCC, e.g. for depletion of tumor cells, virally-infected cells, or immune-modulating cells, etc. One example of the fusion protein is an extracellular domain of a high-affinity variant of human CD 16 A fused to an anti-CD3 antibody or its antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.
    Type: Application
    Filed: May 23, 2019
    Publication date: August 26, 2021
    Applicant: MANYSMART THERAPEUTICS, INC.
    Inventors: HSIN-YI HUANG, Cheng Hao LIAO
  • COMBINATION FOR T-CELL IMMUNOTHERAPY AND USE THEREOF
    Publication number: 20200230236
    Abstract: Combinations including a bispecific T cell activating antigen binding molecule and effector memory ?9?2 T cells. Also methods of using the combinations in treating diseases such as cancers and infectious diseases.
    Type: Application
    Filed: September 21, 2018
    Publication date: July 23, 2020
    Applicant: MANYSMART THERAPEUTICS, INC.
    Inventor: HSIN-YI HUANG